Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England ...
Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in ...
Researchers say cancer's ability to evade treatment and recur is partly due to tumor cells switching between states to ...
Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...
Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a ...
A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...
Scientists have long observed that cancer patients have a lower risk of Alzheimer’s disease. New research reveals a possible ...